CCR Milestones - 2020

continued Nitin Roper, M.D. Nitin Roper, M.D., has been appointed as a Physician-Scientist Early Investigator in the Developmental Therapeutics Branch. His research focuses on high-grade neuroendocrine tumors, including small cell lung, bladder, prostate, pancreatic and non-small cell cancers that transform to high-grade neuroendocrine cancers. S. Cenk Sahinalp, Ph.D. S. Cenk Sahinalp, Ph.D., has joined the Cancer Data Science Laboratory as a Senior Investigator. His research focuses on developing algorithmic methods for managing, storing, communicating and analyzing high-throughput sequencing data, especially in the context of cancer. John ‘Jay’ Schneekloth, Ph.D. John ‘Jay’ Schneekloth, Ph.D., has been awarded tenure at NIH and appointed to Senior Investigator in the Chemical Biology Laboratory. He focuses on identifying and studying small molecules that interact with structured RNA and DNA. Nirali Shah, M.D., M.H.Sc. Nirali Shah, M.D., M.H.Sc., has been appointed as an NIH Lasker Scholar Tenure Track Investigator in the Pediatric Oncology Branch. Her primary research interests focus on translation of immuno- therapeutic approaches to treat high-risk hematologic malignanciesin children, adolescents and young adults. Shy Shorer, M.D. Shy Shorer, M.D., has been appointed as a Senior Clinician in the Office of Sponsor and Regulatory Oversight. His office will oversee safety, clinical monitoring and quality management; provide analytic support; lead the pharmacovigilance program; and maintain high-level expertise regarding FDA regulations. David Takeda, M.D., Ph.D. David Takeda, M.D., Ph.D., has been appointed as an NIH Lasker Scholar Tenure Track Investigator in the Laboratory of Genitourinary Cancer Pathogenesis. His research seeks to understand the role of epigenetic reprogramming in disease progression by combining genomic and epigenomic profiling of patient samples with functional studies in model systems. Masaki Terabe, Ph.D. Masaki Terabe, Ph.D., has been appointed as a Tenure Track Investigator in the Neuro-Oncology Branch. He is working to elucidate the mechanisms of immune regulation of tumor immunity, in particular the roles of regulatory cells including natural killer T cells, regulatory T cells and myeloid-lineage cells. New Faculty 24